Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63
Sex
Women only
Ages
Adults (Child, Adult, Older Adult)
Primary completion
2018-01-12
Last update
2025-05-01

What this trial studies

Menopause is usually associated with an increase in body weight, a change in body composition and fat distribution and a large number of cardio-metabolic changes, such as hypertension, reduction of insulin-sensitivity and dyslipidaemia. The first-line strategy for these complications is the modification of dietary habits and lifestyle in terms of physical activity. Besides, there is also a growing interest in complementary therapies (i.e. nutraceuticals) that can be used alone or in combination to achieve more consistent results.

Conditions in scope

  • Dyslipidemia

Interventions

  • Nutraceutical (Dietary Supplement) — Nutritional counseling plus one pill of an active product (Trixy®) containing Berberine, Tocotrienols and Chlorogenic acid
  • Control (Other) — Nutritional counseling

Who can join

Women only · Adults (Child, Adult, Older Adult)

Inclusion criteria

  • LDL cholesterol \>100 mg/dL
  • Written informed consent available

Exclusion criteria

  • Use of any drug affecting blood lipids
  • Hormone replacement therapy
  • Adherence to a weigh loss diet in the previous 6 months
  • Cancer diagnosis
  • Known thyroid, liver, renal or muscle diseases
  • Any medical or surgical condition which could lead to an inconstant adhesion to the protocol

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Pavia Fondazione IRCCS Policlinico San Matteo Unknown

Status & timeline

  • Overall status: Completed
  • Study type: Interventional
  • Phase: N/A
  • Start date: 2017-03-31
  • Primary completion: 2018-01-12
  • Last update posted: 2025-05-01
  • First posted: 2017-01-12

Lead sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia (Other)

Collaborators: University of Pavia

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • LDL cholesterol (3 months)
    LDL cholesterol

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT03019263 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.